National Cancer Institute News
New Drug Formulary Will Help Expedite Use of Agents in Clinical Trials
The National Cancer Institute (NCI) today launched a new drug formulary (the “NCI Formulary”) that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials. The NCI Formulary could ultimately translate into speeding the availability of more-effective treatment options to patients with cancer.
Who Should Get the HPV Vaccination and Why
Human papillomavirus (HPV) is the most common sexually transmitted infection in the US according to the Centers for Disease Control and Prevention (CDC).
Cancer Facts and Figures: Death Rate Down 25% Since 1991
The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society.
10 Powerful Survivor Stories From 2016
Our featured survivors share words of inspiration, wisdom, hope, and support in these stories about how their lives have been changed by cancer.
Prep Ahead for Healthier Meals
Eating healthy meals and snacks throughout the week is easier when you plan them out and even prepare them ahead of time.
When It’s More Than the Winter Blues
As the fun and festivities become memories, this is the time of year many people feel a little let down or sad. Sadness that doesn’t go away or keeps you from enjoying things you usually like could be a sign of clinical depression.
Top 10 Cancer News Stories of 2016
In 2016 we published stories about new findings in cancer risk factors, treatments, and survivorship issues in children and adults. Our writers and editors have chosen the 10 most significant stories of the year.
Early-phase trial demonstrates shrinkage in pediatric neural tumors
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.
New Cancer Drug Approvals From 2016
In 2016, the FDA approved several new drug treatments for different cancer types that American Cancer Society editors believe will make a significant difference.
How to Prevent Cervical Cancer or Find It Early
During the past few decades, screening has reduced deaths from cervical cancer, as doctors have been able to find cancer early and treat it, or prevent it from ever developing.
- Previous Page Next Page